Wepaticare: Hepatic Protection in Veterinary Medicine – Why Efficacy Does Not Depend on a Single Ingredient

Liver supplements are frequently used in veterinary medicine to support hepatic function in animals with chronic hepatopathies, intoxications, cholestasis or prolonged drug therapies. Although SAMe (S-adenosylmethionine) is often perceived as an essential component, the specialist literature suggests that the clinical efficacy of hepatoprotection does not depend on a single ingredient, but on the combined action of multiple biological mechanisms.If you are a veterinary surgeon, this article analyses the mechanisms of multimodal hepatoprotection and the place of SAMe in context. If you are a pet owner and your dog has liver problems, you will understand why a good liver supplement contains multiple ingredients, not just one, and what each component does.

Quick summary

Liver disease in animals rarely involves a single mechanism. As a rule, several processes are simultaneously involved: inflammation, oxidative stress, hepatocyte membrane damage, alterations in bile flow and, sometimes, fibrotic processes.

SAMe is a methyl group donor involved in the synthesis of glutathione (an intracellular antioxidant). Used alone, its effects are variable. Benefits appear more consistently when it is combined with other hepatoprotective ingredients.

Silymarin (from Silybum marianum) stabilises the cell membrane and has antioxidant and anti-inflammatory properties. Other substances influence lipid metabolism, hepatic detoxification or cell regeneration.

Wepaticare® (WePharm) combines in a single formula: silymarin (Siliphos), dandelion, turmeric, artichoke, Astragalus, Ginkgo biloba, lecithins, vitamin E, B-complex, BCAA, zinc, selenium and Enterococcus faecium. Pleasantly flavoured tablets, 30 per box.

Jump to:

• The role of SAMe in hepatoprotection: useful, but not sufficient alone
• Why liver disease requires a multimodal approach
• Silymarin and other hepatoprotectors with complementary mechanisms
• Full composition of Wepaticare®
• How to administer Wepaticare®
• Clinical implications: how to choose a liver supplement
• Frequently asked questions
• Bibliography
• Further reading

The role of SAMe in hepatoprotection: useful, but not sufficient alone

SAMe (S-adenosylmethionine) is a methyl group donor involved in numerous metabolic reactions and plays an important role in the synthesis of glutathione, one of the main intracellular antioxidants. Experimental studies have shown that SAMe administration can increase hepatic glutathione levels and reduce oxidative stress under certain conditions.

However, clinical data indicate that the effects of SAMe used alone are variable. In many situations, the observed benefits appear when the substance is administered in combination with other hepatoprotective ingredients. Some studies suggest that monotherapy with SAMe may have a limited impact on the progression of liver diseases, whilst complex formulas may offer more consistent results (Center et al., 2005; Anstee & Day, 2012).

What does this mean for owners? SAMe is a useful substance, but a diseased liver needs several types of support simultaneously. A supplement containing only SAMe provides partial protection; one that combines multiple active ingredients can offer a broader spectrum of protection.

Why liver disease requires a multimodal approach

Liver disease in animals is rarely caused by a single mechanism. As a rule, several processes are simultaneously involved:

• Inflammation – the chronic inflammatory response damages hepatic tissue
• Oxidative stress – free radicals attack liver cells
• Hepatocyte membrane damage – the membrane of liver cells becomes vulnerable
• Alterations in bile flow – toxic bile acids accumulate and worsen the lesions
• Fibrotic processes – functional hepatic tissue is replaced by scar tissue

For this reason, modern therapeutic strategies include combinations of substances with complementary actions: antioxidants reduce oxidative stress, choleretic substances support the elimination of toxic bile acids, and membrane-stabilising compounds can limit hepatocyte destruction.

In simpler terms for owners: the liver performs many functions in the body (it filters toxins, produces bile, stores vitamins). When it becomes diseased, several functions are affected simultaneously. This is why a single ingredient cannot solve everything – a team of ingredients is needed, each with its own role.

Silymarin and other hepatoprotectors with complementary mechanisms

Silymarin (extracted from Silybum marianum / milk thistle) and its derivatives are widely used due to their antioxidant, anti-inflammatory and cell membrane-stabilising properties. The Siliphos complex (silybin + phosphatidylcholine) has a superior bioavailability compared with standard silymarin.

Other substances with documented hepatoprotective roles in the literature (Marchegiani et al., 2020):

• Dandelion (Taraxacum officinale) – choleretic effect, supports bile flow
• Turmeric (Curcuma longa) – anti-inflammatory and antioxidant properties
• Artichoke (Cynara scolymus) – choleretic and hepatoprotective effect
• Astragalus membranaceus – immunomodulatory and hepatoprotective properties
• Ginkgo biloba – antioxidant effect
• Lecithins (phosphatidylcholine) – hepatocyte membrane stabilisation, lipid transport
• Vitamin E – fat-soluble antioxidant, protects cell membranes
• B-complex vitamins – essential metabolic cofactors for hepatic function
• BCAA (branched-chain amino acids) – metabolic support in hepatopathies
• Zinc and selenium – enzymatic cofactors with antioxidant roles
• Enterococcus faecium – probiotic, gut-liver axis support

The review literature underscores that there is no universal molecule capable of acting upon all the mechanisms involved in hepatopathies, which explains the growing interest in multimodal formulas.

Full composition of Wepaticare®

Wepaticare® (WePharm) is a nutritional supplement developed to support hepatic function in medium and large-breed dogs, through an approach based on complementary mechanisms of liver protection. It is available as pleasantly flavoured tablets, 30 tablets per box.

Composition per tablet

• Siliphos (Silybin + Phosphatidylcholine complex, from Silybum marianum) – 70 mg
• Vitamin E – 70 mg
• Turmeric (Curcuma longa) – 35 mg
• Dandelion leaf (Taraxacum officinale) – 28 mg
• Zinc – 21 mg
• Lecithins (polyunsaturated phosphatidylcholine) – 14 mg
• Artichoke leaf (Cynara scolymus) – 14 mg
• Astragalus membranaceus – 14 mg
• Ginkgo biloba – 14 mg
• B-vitamin complex (B1: 7 mg, B2: 7 mg, B6: 3.5 mg, B9: 1.04 mg, B12: 0.35 mg)
• Oat bran – 7 mg
• BCAA (L-leucine, L-isoleucine, L-valine)
• Enterococcus faecium – probiotic
• Selenium – 0.07 mg

The formula thus combines 14 active ingredients with complementary mechanisms: antioxidant protection (Siliphos, vitamin E, Ginkgo, selenium), choleretic effect (dandelion, artichoke), anti-inflammatory action (turmeric), membrane stabilisation (lecithins, Siliphos), metabolic support (B-complex, BCAA, zinc) and gut-liver axis support (Enterococcus faecium, oat bran).

This multi-ingredient approach is the same philosophy applied in joint health support with We Joint Plus® (see the article on hydrolysed and native type II collagen) and in haematopoiesis support with WeHemo® (see the article on chelated iron in supporting anaemic patients).

How to administer Wepaticare®

Administration: orally, as they are (pleasantly flavoured for dogs) or mixed into the daily food.

Recommended doses

• Dogs 10-20 kg – 1 tablet/day
• Dogs 20-30 kg – 2 tablets/day
• Dogs over 30 kg – 3 tablets/day

Important: Wepaticare® is formulated for medium and large-breed dogs (over 10 kg). For small-breed dogs or cats, consult your veterinary surgeon for suitable alternatives from the WePharm range.

Clinical implications: how to choose a liver supplement

In clinical practice, the choice of a liver supplement should be based on the mechanisms of action of the ingredients and on the clinical context of the patient, not merely on the presence of a well-known substance.

Formulas that combine multiple components can offer a broader spectrum of action, simultaneously addressing oxidative stress, inflammation and biliary dysfunction.

It is important to emphasise that the absence of SAMe from a supplement does not necessarily mean reduced efficacy. If the product contains ingredients with complementary and well-documented mechanisms, it may have comparable clinical utility.

For owners: when your veterinary surgeon recommends a liver supplement for your dog, do not look only for a single “star” ingredient on the label. What matters is the combination of ingredients that protect the liver on multiple fronts simultaneously. Ask your veterinary surgeon which product is appropriate for your animal’s specific situation.

Frequently asked questions

Bibliography

• Center SA, Warner KL, McCabe J, et al. (2005). Evaluation of the influence of S-adenosylmethionine on systemic and hepatic effects of prednisolone in dogs. Am J Vet Res. 66(2):330-41.
• Marchegiani A, Fruganti A, Gavazza A, et al. (2020). Evidences on Molecules Most Frequently Included in Canine and Feline Complementary Feed to Support Liver Function. Vet Med Int. 2020:9185759.
• Anstee QM, Day CP. (2012). S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility. Journal of Hepatology. 57(5):1097-1109.